Mesoblast (NASDAQ:MESO) Upgraded at Cantor Fitzgerald
Cantor Fitzgerald upgraded shares of Mesoblast (NASDAQ:MESO – Free Report) to a strong-buy rating in a research note released on Tuesday morning,Zacks.com reports. Cantor Fitzgerald also issued estimates for Mesoblast’s FY2025 earnings at ($0.70) EPS. Several other analysts have also issued reports on MESO. Piper Sandler restated an “overweight” rating and issued a $24.00 price […]
Cantor Fitzgerald upgraded shares of Mesoblast (NASDAQ:MESO – Free Report) to a strong-buy rating in a research note released on Tuesday morning,Zacks.com reports. Cantor Fitzgerald also issued estimates for Mesoblast’s FY2025 earnings at ($0.70) EPS. Several other analysts have also issued reports on MESO. Piper Sandler restated an “overweight” rating and issued a $24.00 price […]
